Please assess the completion status of the following clinical trial:

Trial Title: Moderna COVID-19 Vaccine mRNA-1273 Observational Pregnancy Outcome Study

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: COHORT
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Currently pregnant~* The outcome of pregnancy (that is, pregnancy loss or live birth) must not be known at entry.~* Agrees to electronically sign the release of medical information form permitting the study to contact her HCPs (for example, primary care provider \[PCP\], obstetrician, nurse midwife) and the infant's HCP (for example, pediatrician) for medical information.~* Received the Moderna COVID-19 vaccine at any point from 28 days prior to last menstrual period (LMP) throughout pregnancy.~Exclusion Criteria:~* Participant has received any other COVID-19 vaccines at any point from 28 days prior to LMP throughout pregnancy.~* Women currently participating in another investigational device or drug study, currently taking an investigational medicinal product, or having taken an investigational product within 28 days prior to LMP or during pregnancy.

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Moderna COVID-19 Vaccine in Pregnant Women (Type: None): The Moderna COVID-19 Vaccine Pregnancy Registry will collect primary data from pregnant women who have received the Moderna COVID-19 vaccine and their healthcare providers (HCPs).

Based on this trial design, predict the completion outcome and termination type (if applicable).